QR Kodea

Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU

Abstract Background Chemotherapy is a primary treatment for cancer, but its efficacy is often limited by cancer-associated bacteria (CAB) that impair tumor suppressor functions. Our previous research found that Mycoplasma fermentans DnaK, a chaperone protein, impairs p53 activities, which are essent...

Deskribapen osoa

Gorde:
Egile Nagusiak: Francesca Benedetti, Emmanuel F. Mongodin, Jonathan H. Badger, Arshi Munawwar, Ashley Cellini, Weirong Yuan, Giovannino Silvestri, Carl N. Kraus, Simone Marini, Chozha V. Rathinam, Marco Salemi, Hervé Tettelin, Robert C. Gallo, Davide Zella
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2024-03-01
Saila:Journal of Translational Medicine
Gaiak:
DnaK
Mycoplasma
Fusobacterium
Cisplatin
5FU
TCGA
Sarrera elektronikoa:https://doi.org/10.1186/s12967-024-05078-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak